To determine whether human iPSCs could induce tumor-responsive CTLs, we prepared iPSL/DCs generated from peripheral blood cells carrying HLA-A33 and co-cultured them with CD8+ T lymphocytes in vitro. The gene discussed is CD8A; the disease is neoplasm.